JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB195289

Anti-USP22 antibody [EPR18945]

  • BOND RX™ Validated
  • RabMAb
  • Recombinant
  • KO Validated
  • What is this?

5

(1 Review)

|

(40 Publications)

Anti-USP22 antibody [EPR18945] (ab195289) is a rabbit monoclonal antibody detecting USP22 in Western Blot, IP, IHC-P. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications

View Alternative Names

KIAA1063, USP3L, USP22, Ubiquitin carboxyl-terminal hydrolase 22, Deubiquitinating enzyme 22, Ubiquitin thioesterase 22, Ubiquitin-specific-processing protease 22

11 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)

Immunohistochemical analysis of paraffin-embedded Human cerebrum tissue labeling USP22 with ab195289 at 1/100 followed by a Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) Ready to use. Nuclear staining on human cerebrum. The section was incubated with ab195289 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) Ready to use.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)

Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue labeling USP22 with ab195289 at 1/100 followed by a Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) at Ready to use dilution. Nuclear staining on human breast carcinoma. The section was incubated with ab195289 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) Ready to use.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins

Immunoprecipitation - Anti-USP22 antibody [EPR18945] (AB195289)
  • IP

Supplier Data

Immunoprecipitation - Anti-USP22 antibody [EPR18945] (AB195289)

USP22 was immunoprecipitated from 0.35 mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab195289 at 1/40 dilution. Western blot was performed from the immunoprecipitate using ab195289 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HeLa whole cell lysate, 10μg (Input).

Lane 2 : ab195289 IP in HeLa whole cell lysate.

Lane 3 : Rabbit IgG,monoclonal [EPR25A]- Isotype Control (ab172730) instead of ab195289 in HeLa whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 3 seconds.

All lanes:

Immunoprecipitation - Anti-USP22 antibody [EPR18945] (ab195289)

Predicted band size: 60 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)

Immunohistochemical analysis of paraffin-embedded Rat cerebrum tissue labeling USP22 with ab195289 at 1/1000 followed by a Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) Ready to use. Nuclear staining on rat cerebrum. The section was incubated with ab195289 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) Ready to use.

Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-USP22 antibody [EPR18945] (AB195289)

Immunohistochemical analysis of paraffin-embedded Mouse cerebrum tissue labeling USP22 with ab195289 at 1/1000 followed by a Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) Ready to use. Nuclear staining on mouse cerebrum. The section was incubated with ab195289 for 30 mins at room temperature.The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) Ready to use.

Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)
  • WB

Lab

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)

Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : USP22 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HEK293 whole cell lysate (20 μg)
Lane 4 : HeLa whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab195289 observed at 60 kDa. Red - loading control, ab9484, observed at 37 kDa.

ab195289 was shown to specifically react with USP22 in wild-type HAP1 cells. No band was observed when knockout samples were examined. Wild-type and USP22 knockout samples were subjected to SDS-PAGE. ab195289 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at a 1/2000 dilution and 1/20,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1/20,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-USP22 antibody [EPR18945] (ab195289)

Predicted band size: 60 kDa

false

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)
  • WB

Lab

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)

False colour image of Western blot : Anti-USP22 antibody [EPR18945] staining at 1/2000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab195289 was shown to bind specifically to USP22. A band was observed at 59 kDa in wild-type HeLa cell lysates with no signal observed at this size in usp22 knockout cell line ab264888 (knockout cell lysate ab257789). To generate this image, wild-type and usp22 knockout HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in fluorescent western blot (TBS-based) blocking solution before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-USP22 antibody [EPR18945] (ab195289) at 1/2000 dilution

Lane 1:

Western blot - Human USP22 knockout HeLa cell lysate (<a href='/en-us/products/cell-lysates/human-usp22-knockout-hela-cell-lysate-ab257789'>ab257789</a>)

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

USP22 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human USP22 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-usp22-knockout-hela-cell-line-ab264888'>ab264888</a>)

Predicted band size: 60 kDa

Observed band size: 59 kDa

false

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)
  • WB

Supplier Data

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-USP22 antibody [EPR18945] (ab195289) at 1/2000 dilution

Lane 1:

Human fetal liver lysate at 10 µg

Lane 2:

Human fetal heart lysate at 10 µg

Lane 3:

Human fetal kidney lysate at 10 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/10000 dilution

Predicted band size: 60 kDa

Observed band size: 60 kDa

false

Exposure time: 3min

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)
  • WB

Supplier Data

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure times : Lane 1, 2, 3, 4, 5 and 6 : 30 seconds; Lane 7 : 15 seconds.

All lanes:

Western blot - Anti-USP22 antibody [EPR18945] (ab195289) at 1/2000 dilution

Lane 1:

HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 2:

HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 20 µg

Lane 3:

Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 20 µg

Lane 4:

HepG2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 20 µg

Lane 5:

MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg

Lane 6:

Neuro-2a (Mouse neuroblastoma cell line) whole cell lysate at 20 µg

Lane 7:

F9 (Mouse embryonic testicular cancer cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 60 kDa

Observed band size: 60 kDa

false

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)
  • WB

Lab

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)

Lane 1 : Wild type HAP1 whole cell lysate (20 μg)
Lane 2 : USP22 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate (20 μg)

ab195289 was shown to specifically recognize USP22 when USP22 knockout samples were used. Wild-type and knockout samples were subjected to SDS-PAGE. ab195289 (1/2000) and ab181602 (Rabbit anti GAPDH loading control) were incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/100,000 dilution.

All lanes:

Western blot - Anti-USP22 antibody [EPR18945] (ab195289)

Predicted band size: 60 kDa

Observed band size: 65 kDa

false

Exposure time: 15s

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)
  • WB

Supplier Data

Western blot - Anti-USP22 antibody [EPR18945] (AB195289)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure times : Lane 1, 2, 3 and 4 : 3 minutes; Lane 5, 6, 7 and 8 : 30 seconds.

All lanes:

Western blot - Anti-USP22 antibody [EPR18945] (ab195289) at 1/2000 dilution

Lane 1:

Mouse brain lysate at 10 µg

Lane 2:

Mouse spleen lysate at 10 µg

Lane 3:

Rat brain lysate at 10 µg

Lane 4:

Rat spleen lysate at 10 µg

Lane 5:

C6 (Rat glial tumor cell line) whole cell lysate at 10 µg

Lane 6:

RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg

Lane 7:

PC-12 (Rat adrenal gland pheochromocytoma cell line) whole cell lysate at 10 µg

Lane 8:

NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 60 kDa

Observed band size: 60 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR18945

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, IHC-P, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/40", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-USP22 antibody [EPR18945] (ab195289) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.

What is the molecular weight of USP22?
Anti-USP22 [EPR18945] (ab195289) specifically detects a band for USP22 (UniProt: Q9UPT9) at a molecular weight of 60kDa.

Trusted by the scientific community
Anti-USP22 [EPR18945] (ab195289) was first used in a scientific publication in 2016 and has been cited over 30 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-USP22 antibody [EPR18945] (ab195289) has been confirmed by Western blot testing in USP22 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EPR18945] also available for your convenience: ab195289, Alexa Fluor® 647 - ab225398, Alexa Fluor® 488 - ab225399, Carrier free - ab238948

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

USP22 also known as ubiquitin-specific protease 22 is an enzyme belonging to the class of deubiquitinating enzymes (DUBs). It is characterized by the ability to remove ubiquitin moieties from target proteins which can alter their stability and function. Carrying an approximate mass of 59 kDa USP22 localizes mainly in the nucleus. Expression of USP22 is widespread across a range of tissues with higher levels identified in tissues exhibiting high proliferative capacity.
Biological function summary

Removal of ubiquitin by USP22 regulates gene expression by modulating histone modifications. USP22 acts as a part of the Spt-Ada-Gcn5 acetyltransferase (SAGA) complex which plays a significant role in transcriptional regulation. Through its deubiquitinating activity USP22 alters the ubiquitination status of histone proteins thereby impacting chromatin dynamics and gene transcription.

Pathways

USP22 takes part in critical pathways like the ubiquitin-proteasome system and chromosome structure modulation. Within these processes USP22 closely interacts with proteins such as SAGA complex members and histone H2B. Its activity within this system highlights roles in transcriptional control and cellular growth important for maintaining cellular homeostasis and regulating cell cycle progression.

USP22 shows strong implications in several types of cancer including colorectal and prostate cancer. Abnormal expression levels can alter the transcriptional landscape contributing to tumor progression and metastasis. Further USP22 links to other proteins like MYC in the cancer context highlighting its importance in oncogenic pathways. This connection suggests that targeting USP22 might offer therapeutic potential in treating cancers where its expression is dysregulated.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Deubiquitinase that plays a role in several cellular processes including transcriptional regulation, cell cycle progression or innate immunity. As part of the transcription regulatory histone acetylation (HAT) complex SAGA, catalyzes the deubiquitination of both histones H2A and H2B, thereby acting as a transcriptional coactivator (PubMed : 18206972, PubMed : 18206973, PubMed : 18469533). Recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Facilitates cell-cycle progression by stabilizing CCNB1 and antagonizing its proteasome-mediated degradation in a cell cycle-specific manner (PubMed : 27030811). Modulates cell cycle progression and apoptosis also by antagonizing TP53 transcriptional activation through deacetylase SIRT1 stabilization (PubMed : 22542455). Plays multiple roles in immunity and inflammation. Participates in antiviral response by deubiquitinating the importin KPNA2, leading to IRF3 nuclear translocation and subsequent type I interferon production (PubMed : 32130408). Acts as a central regulator of type III IFN signaling by negatively regulating STING1 activation and ubiquitination (PubMed : 35933402). Inhibits NLRP3 inflammasome activation by promoting NLRP3 degradation through ATG5-dependent autophagy (By similarity). Deubiquitinates CD274 to induce its stabilization and thereby participates in maintenance of immune tolerance to self (PubMed : 31399419). Controls necroptotic cell death by regulating RIPK3 phosphorylation and ubiquitination (PubMed : 33369872). During bacterial infection, promotes pro-inflammatory response by targeting TRAF6 and removing its 'Lys-48'-linked polyubiquitination (By similarity).
See full target information USP22

Publications (40)

Recent publications for all applications. Explore the full list and refine your search

Clinical and translational medicine 15:e70324 PubMed40341781

2025

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaochen Wang,Yijie Su,Bei Lan,Xuanyuan Li,Bodi Zhang,Liang Zhang,Yingmei Wang,Chunze Zhang,Chenghao Xuan

Journal of virology 99:e0223424 PubMed40183543

2025

Targeting USP22 to promote K63-linked ubiquitination and degradation of SARS-CoV-2 nucleocapsid protein.

Applications

Unspecified application

Species

Unspecified reactive species

Xin Xiao,Shifeng Li,Zhijin Zheng,Yingying Ji,Qian Du,Yibo Zuo,Ying Miao,Yukang Yuan,Hui Zheng,Fang Huang,Jun Wang

Communications biology 8:214 PubMed39934243

2025

Inhibition of SCF/USP22-dependent nuclear β-catenin ubiquitylation mediates cerebral ischemic tolerance.

Applications

Unspecified application

Species

Unspecified reactive species

Yunyan Zuo,Jiahui Xue,Haixia Wen,Lixuan Zhan,Meiyan Chen,Weiwen Sun,En Xu

Cancer biology & therapy 25:2427415 PubMed39530604

2024

A positive feedback loop of SRSF9/USP22/ZEB1 promotes the progression of ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Wang,Ming Hu,Jie Min,Xin Li

iScience 27:110592 PubMed39246448

2024

Ubiquitin-specific peptidase 22 controls integrin-dependent cancer cell stemness and metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Kun Liu,Qiong Gao,Yuzhi Jia,Juncheng Wei,Shuvam Mohan Chaudhuri,Shengnan Wang,Amy Tang,Nikita Lavanya Mani,Radhika Iyer,Yang Cheng,Beixue Gao,Weiyuan Lu,Zhaolin Sun,Bin Zhang,Huiping Liu,Deyu Fang

Translational oncology 49:102104 PubMed39197387

2024

The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression.

Applications

Unspecified application

Species

Unspecified reactive species

Fanghua Xu,Xiangda Xu,Huanhuan Deng,Zhaojun Yu,Jianbiao Huang,Leihong Deng,Haichao Chao

MedComm 5:e684 PubMed39135915

2024

Ubiquitin-specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Huiyan Sun,Yu Meng,Lei Yao,Songtao Du,Yayun Li,Qian Zhou,Yihuang Liu,Yating Dian,Yuming Sun,Xiaomin Wang,Xiao-Wei Liang,Guangtong Deng,Xiang Chen,Furong Zeng

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2308045 PubMed38520088

2024

EZH2 Inhibition Enhances PD-L1 Protein Stability Through USP22-Mediated Deubiquitination in Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaqi Huang,Qianqian Yin,Yuqing Wang,Xin Zhou,Yunyun Guo,Yuanjun Tang,Rui Cheng,Xiaotong Yu,Jie Zhang,Chen Huang,Zhanya Huang,Jianlin Zhang,Zhengyang Guo,Xiao Huo,Yan Sun,Yanfang Li,Hao Wang,Jianling Yang,Lixiang Xue

Cell communication and signaling : CCS 22:120 PubMed38347585

2024

USP22 supports the aggressive behavior of basal-like breast cancer by stimulating cellular respiration.

Applications

Unspecified application

Species

Unspecified reactive species

Evangelos Prokakis,Husam Bamahmoud,Shaishavi Jansari,Lena Fritsche,Alexander Dietz,Angela Boshnakovska,Peter Rehling,Steven A Johnsen,Julia Gallwas,Florian Wegwitz

Frontiers in pharmacology 14:1164333 PubMed37324479

2023

Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22/Sirt 1.

Applications

Unspecified application

Species

Unspecified reactive species

Shuai Wang,Jie Bai,Yilin Che,Weikun Qu,Jing Li
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com